A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial.
about
Bioresorbable scaffolds for percutaneous coronary interventionsBioresorbable scaffolds: a new paradigm in percutaneous coronary interventionBioresorbable vascular scaffold implantation in acute coronary syndromes: clinical evidence, tips and tricksThe Safety and Efficacy of Absorb Bioresorbable Vascular Scaffold: A Systematic ReviewBioresorbable scaffolds: current evidence and ongoing clinical trialsBioresorbable Scaffolds: Current Evidences in the Treatment of Coronary Artery DiseaseSurface Modification of Biodegradable Polymers towards Better Biocompatibility and Lower ThrombogenicityApplications of optical coherence tomography in cardiovascular medicine, part 1.Advances in stent technologies and their effect on clinical efficacy and safetyThe invasive assessment of coronary atherosclerosis and stents using optical coherence tomography: a clinical updateInterstudy reproducibility of the second generation, Fourier domain optical coherence tomography in patients with coronary artery disease and comparison with intravascular ultrasound: a study applying automated contour detectionQuantitative multi-modality imaging analysis of a fully bioresorbable stent: a head-to-head comparison between QCA, IVUS and OCT.Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenariosBiomaterials in cardiovascular research: applications and clinical implications.Everolimus-Eluting Bioresorbable Vascular Scaffold in Real World Practice - A Single Center Experience.The role of stents in the treatment of congenital heart disease: Current status and future perspectivesPolymeric stent materials dysregulate macrophage and endothelial cell functions: implications for coronary artery stent.Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.Impact of polymer structure and composition on fully resorbable endovascular scaffold performance.Drug-eluting stentsPrognostic significance of endothelial dysfunction in patients undergoing percutaneous coronary intervention in the era of drug-eluting stentsThe duration of balloon inflation affects the luminal diameter of coronary segments after bioresorbable vascular scaffolds deployment.Bioresorbable Stents in PCI.Degree of bioresorbable vascular scaffold expansion modulates loss of essential function.Everolimus-eluting coronary stentsCONSORT 2010 statement: extension to randomised pilot and feasibility trialsRole of invasive imaging in acute and long-term assessment of bioresorbable scaffold technology.Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffoldReal-life data regarding acute procedural success and 1-year clinical outcome of desolve bioresorbable scaffolds.Long-term outcome of bioresorbable vascular scaffolds for the treatment of coronary artery disease: a meta-analysis of RCTsDrug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysisHigh technology in medicine: lessons from cardiovascular innovations and future perspective.Drug-eluting stents - what should be improved?A review of current devices and a look at new technology: drug-eluting stents.Multiplicity of morphologies in poly (l-lactide) bioresorbable vascular scaffolds.Xience V everolimus-eluting coronary stent.Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial.Bioabsorbable stent quo vadis: a case for nano-theranostics.Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19'Benefits of and safety concerns associated with drug-eluting coronary stents.
P2860
Q21972838-28723852-8BE2-46EE-BBC8-A4BCA0B9B3C3Q26766579-364CFF73-E747-4D84-A7B7-ED056AF3829CQ26775130-69BB493B-EFFB-4997-BFE3-B5F29B339226Q26782136-28EF4639-5387-40BE-89F1-38619680E19BQ26863627-2DA2B4D2-6DD9-477B-B310-FBC9C61C821CQ28076491-41E05746-78CE-43C8-A65E-7B3AC9FA94A6Q28551353-3F6BB3F3-FC3C-4D07-958D-934004052F7FQ28652684-0CB31E61-05A2-4774-AE64-E3BE661D00A7Q28972437-6164ABC4-4CB5-4A91-A7B1-79107D3C6D90Q30442855-777146B6-445F-45D1-B8D9-5D4E89E9D72CQ30458995-50418307-4FDF-42FB-A4E5-FFEFB0894802Q30513311-139A1EAB-72BF-4CC6-82A5-7C84262352AEQ30619558-7DCF31B8-C514-45D5-A4D0-77188443D47EQ33660457-0A2F5DD8-B88F-4BFC-BF54-4E4C78ED1802Q33729836-A296B456-4871-4A32-9B81-6B16E0E59FA4Q33735747-136116C2-85AA-45D4-8893-2CB6FFD490A1Q33806410-F38508DA-830D-4FDD-AEE3-48FA91F6C8B8Q33839384-F85A4465-7555-401C-ABD7-FBC94CE32D1CQ33924780-78688301-7899-4AB3-A8C2-1F0340EFE5B2Q34091036-AC8EF116-4AEE-4D19-8534-26B8ADEC5E57Q35785555-9913FA5D-9FE9-4744-A088-20323A73B020Q35865733-3078B6CD-1B65-46CC-8F86-61389AADCB1CQ36055029-5CB70590-1F10-4116-ADAE-ACAFA75A09AFQ36096161-EBF95B89-C183-4D22-809E-173A12C282A2Q36160432-C9F55855-048E-4B61-97D3-BF7C449D1E0EQ36173563-5300F84E-B645-4C9F-8DD4-B037F505094DQ36178330-BD39CBB0-37C2-499A-B995-6D655025E0FFQ36296085-43364E0B-5267-4346-AD45-C7EC6DB6842CQ36356024-2B449625-9F77-41E9-A678-4420D9D1F46FQ36395245-AB5DF14D-8257-4AE8-9DDB-6683A97C48BDQ36856022-81CE9970-4D6E-4E7B-90A2-5BD6DDBEBE48Q36919252-CDD31116-938E-4FDD-8D8E-65A20E877B66Q37144221-F466CBF0-08C8-4362-ADD1-9A6880B37EB4Q37357342-329D3785-85CC-4453-B201-A681BB19A046Q37369411-AC34FB44-9968-4DBE-BCC3-0CDC4EC2AD90Q37472070-28CE9A0A-9A93-47D2-992C-F9A3FD89EAC4Q37588855-F5F982D8-A058-44A2-8EEE-7374915D4451Q37663672-0E7572C7-37C8-4E37-9B50-834AD97DA249Q37671897-4667137A-C748-4862-9111-12CC7F980A34Q37707419-58C18638-A83A-4610-86DB-3209D88807B1
P2860
A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
A bioabsorbable everolimus-elu ...... prospective open-label trial.
@ast
A bioabsorbable everolimus-elu ...... prospective open-label trial.
@en
A bioabsorbable everolimus-elu ...... e-novo coronary artery lesions
@nl
type
label
A bioabsorbable everolimus-elu ...... prospective open-label trial.
@ast
A bioabsorbable everolimus-elu ...... prospective open-label trial.
@en
A bioabsorbable everolimus-elu ...... e-novo coronary artery lesions
@nl
prefLabel
A bioabsorbable everolimus-elu ...... prospective open-label trial.
@ast
A bioabsorbable everolimus-elu ...... prospective open-label trial.
@en
A bioabsorbable everolimus-elu ...... e-novo coronary artery lesions
@nl
P2093
P1433
P1476
A bioabsorbable everolimus-elu ...... prospective open-label trial.
@en
P2093
Evelyn Regar
Hector M Garcia-Garcia
John A Ormiston
Leif Thuesen
Mark W I Webster
Robert McGreevy
Susan Veldhof
Yoshinobu Onuma
P304
P356
10.1016/S0140-6736(08)60415-8
P407
P577
2008-03-01T00:00:00Z